Search
Search Term

Hematologic Malignancies

HEMATOLOGIC
MALIGNANCIES

The Hematologic Malignancies (HEM) research program focuses on advancing our understanding of molecular pathogenesis and treatment of leukemias and lymphomas.

About the Program

MEMBERSHIP RESOURCES

BECOME A MEMBER

EVENTS

Program Highlights

Neuronal aging causes mislocalization of splicing proteins and unchecked cellular stress

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL

Beyond the hippocampus: Limbic white matter injury implicated in post-radiation memory performance in primary brain tumor patients

Inside the Lab: Researcher Spotlight with Catriona Jamieson, MD, PhD

News & Discoveries

Diane M. Simeone, MD

Establishing Novel Models of Interdisciplinary Care to Improve Survival Outcomes in Patients with Cancer

Michelle Brubaker and Family

Take that Cancer, You Big Jerk: How Clinical Trials Saved Me

UC San Diego scientists in a lab

To Study Cancer “Kill Switch,” UC San Diego Scientists Will Send Stem Cells to Space